This observational case study examined the association of inter- and intraday energy intake and exercise energy expenditure with bone health, menstrual status and hematological factors in a female triathlete. The study spanned 7 months whereby energy intake and exercise energy expenditure were monitored three times (13 d); 16 blood samples were taken, urinary hormones were assessed for 3 months, and bone mineral density was measured twice. Energy availability tended to be sustained below 30 kcal/kg FFM/d and intraday energy intake patterns were often “back-loaded” with approximately 46% of energy consumed after 6 p.m. Most triiodothyronine values were low (1.1–1.2nmol/L) and supportive of reduced energy availability. The athlete had suppressed estradiol (105.1 ± 71.7pmol/L) and progesterone (1.79 ±1.19nmol/L) concentrations as well as urinary sex-steroid metabolites during the entire monitoring period. Lumbar spine (L1-L4) bone mineral density was low (age-matched Z-score −1.4 to −1.5). Despite these health related maladies the athlete was able to perform typical weekly training loads (swim: 30–40 km, bike: 120–300 km, run 45–70 km) and was competitive as indicated by her continued improvement in ITU World Ranking during and beyond the assessment period. There is a delicate balance between health and performance that can become blurred especially for endurance athletes. Education (athletes, coaches, parents) and continued monitoring of specific indicators will enable evidence-based recommendations to be provided and help reduced the risk of health related issues while maximizing performance gains. Future research needs to longitudinally examine how performance on standardized tests in each discipline (e.g., 800-m swim, 20-km time trial, 5-km run) is impacted when aspects of the female athlete triad are present.
Jason D. Vescovi and Jaci L. VanHeest
Jason D. Vescovi, Teena M. Murray, and Jaci L. VanHeest
The primary purpose of this study was to determine whether positional profiling is possible for elite ice hockey players by examining anthropometric characteristics and physiological performance. In addition, performance ranges and percentiles were determined for each position (forwards, defensemen, and goalkeepers) on all dependent variables.
A retrospective, cross-sectional study design was used with performance data from ice hockey players (mean age = 18.0 ± 0.6 years) attending the 2001 (n = 74), 2002 (n = 84), and 2003 (n = 92) Combines. Four anthropometric characteristics and 12 performance tests were the dependent variables. A 3 × 3 (position × year) 2-way ANOVA was used to determine whether any significant interactions were present. No significant interactions were observed, so the data were collapsed over the 3-year period and positional characteristics were analyzed using a 1-way ANOVA.
Defenders were heavier and/or taller compared with the other 2 positions (P ≤ .01), whereas goalkeepers showed greater body-fat percentage compared with that of forwards (P = .001). It was found that goalkeepers had significantly lower strength measures for the upper body (P ≤ .043) and lower anaerobic capacity (P ≤ .039) values compared with at least one other position, but they had greater flexibility (P ≤ .013). No positional differences were observed for the broad jump, vertical jump, aerobic power, or curl-ups.
The current findings provide evidence supporting the use of anthropometric measurements, upper body strength, and anaerobic capacity to effectively distinguish among positions for elite-level ice hockey players.
Jason D. Vescovi, Teena M. Murray, Kelly A. Fiala, and Jaci L. VanHeest
The primary purpose of this study was to determine whether tests performed at the National Hockey League (NHL) Combine could distinguish draft status (ie, the round selected). A secondary aim was to provide performance ranges and percentiles for each of the dependent variables.
A retrospective, cross-sectional study design was used with performance data and draft order from 2001, 2002, and 2003 Combine participants. Draft round was divided into 5 classifications (rounds 1, 2, 3, 4, and 5 through 9), and performances on 12 physical tests served as dependent variables. Three multiple analyses of covariance (MANCOVAs) were used to determine the significance of performance scores at the NHL Combine on draft selection. Age (years), body mass (kg), height (cm), and percentage body fat were treated as covariates.
Overall, MANCOVA results indicated no significant effect of performance on draft selection for 2001, 2002, or 2003. Subsequent univariate tests revealed that no single dependent variable was able to distinguish between draft rounds for any of the 3 years sampled.
Using draft status as an indicator of ice hockey performance, it appears that off-ice tests cannot accurately predict ice hockey playing ability in an elite group of athletes. This might stem from homogeneity of the Combine participants, a lack of validity of the tests, or other factors (eg, on-ice hockey skills, psychological variables, etc) that play a role in draft selection.
Jennifer K. Ormerod, Tabatha A. Elliott, Timothy P. Scheett, Jaci L. VanHeest, Lawrence E. Armstrong, and Carl M. Maresh
The purposes of this study were to characterize measures of fluid intake and perception of thirst in women over a 6-week period of exercise-heat acclimation and outdoor training and examine if this lengthy acclimation period would result in changes in fluid intake that differ from those previously reported in men utilizing a shorter acclimation protocol of 8–10 days. Voluntary water intake (11–17 °C) and perception of thirst were measured in a group of 5 women (21–26 yr) undergoing exercise-heat acclimation for 90 min/day, 3 days/wk (36 °C, rh 50–70%) and outdoor training 3 days/wk for 6 weeks. Decreased drinking during acclimation was characterized by a decrease in the number of drinks (35 ± 10 to 17 ± 5; p < .05), greater time to first drink (9.9 ± 2.0 to 23.1 ± 4.7 min; p < .05), and a decrease in total volume ingested per week (3310 ± 810 to 1849 ± 446 ml; p < .05) through the 6-week study. Mean perceived thirst measurements remained low and showed only slight variance (3 ± 0.4 to 5 ± 0.4). These observations support a psycho-physiological response pattern different than that previously observed during 8–10 day acclimation protocols in men.
Jaci L. VanHeest, Jim Stoppani, Tim P. Scheett, Valerie Collins, Melissa Roti, Jeffrey Anderson, George J. Allen, Jay Hoffman, William J. Kraemer, and Carl M. Maresh
To determine the effects of Vicoprofen® and ibuprofen on aerobic performance, agility, and pain after exercise-induced muscle damage.
Double-blind randomized, placebo-controlled, repeated-dose clinical trial.
Human-performance and sports-medicine laboratory.
36 healthy men.
Methods and Measures:
Baseline testing was performed, 72 hours after which subjects performed eccentric exercise to induce muscle damage. They were evaluated for pain 24 hours postdamage and placed randomly into 3 groups: Vicoprofen (VIC), ibuprofen, or placebo (P). Postdamage testing was performed every day for 5 days. Subjects performed an economy run and a t-agility test to determine exercise performance.
The drugs had no significant effect on performance throughout the 5-day evaluation period. Pain was lower at days 4 and 5 in the VIC group than in P.
It appears that Vicoprofen reduced pain after muscle damage, but the drug interventions did not enhance performance in aerobic and agility tasks.
William J. Kraemer, Ana L. Gómez, Nicholas A. Ratamess, Jay R. Hoffman, Jeff S. Volek, Martyn R. Rubin, Timothy P. Scheett, Michael R. McGuigan, Duncan French, Jaci L. VanHeest, Robbin B. Wickham, Brandon Doan, Scott A. Mazzetti, Robert U. Newton, and Carl M. Maresh
To determine the effects of Vicoprofen®, ibuprofen, and placebo on anaerobic performance and pain relief after resistance-exercise-induced muscle damage.
Randomized, controlled clinical study.
University human-performance/sports-medicine laboratory.
36 healthy men.
Methods and Measures:
After baseline testing (72 h), participants performed an eccentric-exercise protocol. Each was evaluated for pain 24 h later and randomly assigned to a Vicoprofen (VIC), ibuprofen (IBU), or placebo (P) group. Postexercise testing was performed every 24 h for 4 d.
Significantly greater muscle force, power, and total work were observed in VIC than in P (P < .05) for most time points and for IBU at 48 h.
Anaerobic performance is enhanced with VIC, especially within the first 24 h after significant muscle-tissue damage. The greater performances observed at 48 h might be a result of less damage at this time point with VIC treatment.